Volume 21, Issue 11 e13054
GENETICS

Epigenetic regulation of white adipose tissue in the onset of obesity and metabolic diseases

Daniel Castellano-Castillo

Daniel Castellano-Castillo

Hospital Clínico Universitario Virgen de la Victoria, Instituto de Investigación Biomédica de Málaga (IBIMA), Universidad de Málaga, Málaga, Spain

Search for more papers by this author
Bruno Ramos-Molina

Bruno Ramos-Molina

Hospital Universitario Virgen de la Arrixaca, Instituto Murciano de Investigación Biosanitaria (IMIB-Arrixaca), Murcia, Spain

Search for more papers by this author
Fernando Cardona

Corresponding Author

Fernando Cardona

Hospital Clínico Universitario Virgen de la Victoria, Instituto de Investigación Biomédica de Málaga (IBIMA), Universidad de Málaga, Málaga, Spain

Correspondence

Fernando Cardona, Hospital Clínico Universitario Virgen de la Victoria, Instituto Biomédico de Investigación de Málaga (IBIMA), 29010 Malaga, Spain.

Email: [email protected]

Search for more papers by this author
María Isabel Queipo-Ortuño

María Isabel Queipo-Ortuño

Unidad de Gestión Clínica Intercentros de Oncología Medica, Hospitales Universitarios Regional y Virgen de la Victoria, Instituto de Investigación Biomédica de Málaga (IBIMA)-CIMES-UMA, Universidad de Málaga, Málaga, Spain

Search for more papers by this author
First published: 15 June 2020
Citations: 15

Daniel Castellano-Castillo and Bruno Ramos-Molina contributed equally.

Daniel Castellano-Castillo is currently at Institute of Food, Nutrition and Health, ETH, CH-8603, Schwerzenbach, Switzerland.

Summary

Obesity and metabolic syndrome are among the most prevalent health problems in developed countries. The impairment of adipose tissue (AT) function is partially responsible for the aetiology of these conditions. Epigenetics refers to several processes that add modifications to either the DNA or chromatin architectural proteins (histones). These processes can regulate gene expression, chromatin compaction and DNA repair. Epigenetics includes mechanisms by which the cell can adapt the cellular response to the environmental conditions. Here, we review the role of epigenetics in the onset of obesity and related metabolic disorders, with special focus on AT. We highlight the importance of nutrients and lifestyle in the regulation of the epigenetic mechanisms and how they can impact on AT plasticity and function in obesity and metabolic diseases. Thus, the epigenetic landscape emerges as a fine-tune regulator of the cellular responses according to the energetic, metabolic and physiological conditions of the cell. Alterations in metabolic pathways deregulated during obesity and metabolic syndrome could in part explain the disturbances in the epigenetic marks of the AT in these disorders. The understanding of how this epigenetic deregulation may affect AT biology and function could lead to new therapeutic approaches based on epigenetic strategies.

CONFLICT OF INTEREST

No conflict of interest was declared.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.